Health Canada Publishes Warning About Benlysta’s Mental Health Risks
Lupus is an autoimmune disease that still has many years ahead of it before it is properly understood. In the meantime, many doctors prescribe a variety of medications to help reduce and manage the symptoms of this chronic disease. Many medications are carefully tested and scrutinized before going on the market but despite this, some … [Read more...] about Health Canada Publishes Warning About Benlysta’s Mental Health Risks
Health Canada Issues Safety Alert for Lupus Drug
OTTAWA, Ontario, Canada — Health Canada, the governmental organization who oversees the safety of medications and medical therapies in Canada, issued an urgent safety warning to people taking the intravenous drug BENLYSTA (belimumab) for SLE or systemic lupus erythematosus (lupus) could experience substantial mental health disorders … [Read more...] about Health Canada Issues Safety Alert for Lupus Drug
Lupus Medication Can Lead to Depression, Suicide
OTTAWA, Ontario, Canada — On April 4, 2019, Health Canada announced that the lupus drug BENLYSTA (belimumab) might cause depression, suicidal thoughts, or behavior that leads to self-injury. Health Canada warns physicians and patients battling lupus to be wary of any symptoms indicative of depression while taking BENLYSTA (belimumab) … [Read more...] about Lupus Medication Can Lead to Depression, Suicide
